Skip to content

Compression therapy in the EU

Compression therapy in the EU - MDI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015815
Enrollment
116
Registered
2018-11-05
Start date
2018-11-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the veins, lymph vessels and lymph nodes

Interventions

Group 1: One-time survey of the study participants using a questionnaire

Sponsors

Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Ruhr-Universität Bochum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: For the industry: - Manufacturing/distribution of compression media, member of the ICC or the expert group known as a corresponding industry partner. For the doctors: - medical compression expert appointed by the president of a phlebological society of an EU country

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

MeasureTime frame
Use of compression therapy in EU countries - For industry: o Standards o Pressure classes o Regulation o Distribution channels o Reimbursement of compression equipment. - For physicians: o Recommendation on the use of compression therapy in various clinical scenarios

Secondary

MeasureTime frame
no secondary endpoints

Countries

Germany

Contacts

Public ContactMaren Hoffmann

phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Ruhr-Universität Bochum

m.hoffmann@klinikum-bochum.de+492348792274

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026